Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ESYBRECHE: Synacthen for post-dural puncture syndrome
2015-003357-17Phase 2Completed
- Sponsor
- Hospices Civils de Lyon
- Start
- Oct 2016
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in post-dural puncture headache (PDPH) comparing Synacthen with Placebo (2 arms). Started Oct 2016; status: completed.
02
Drugs
tetracosactide hexaacetate
03
Conditions
post-dural puncture headache (PDPH)
Beyond the preview
Go deeper on 2015-003357-17.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-003357-17.